(Q36700767)

English

Identification of tissue-type plasminogen activator-specific plasminogen activator inhibitor-1 mutants. Evidence that second sites of interaction contribute to target specificity.

scientific article published on April 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7721851%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

Identification of tissue-type plasminogen activator-specific plasminogen activator inhibitor-1 mutants. Evidence that second sites of interaction contribute to target specificity (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7721851%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference

based on heuristic

inferred from title

Daniel A. Lawrence

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7721851%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

author name string

P M Sherman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7721851%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

I M Verhamme

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7721851%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

D Paielli

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7721851%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

J D Shore

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7721851%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

D Ginsburg

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7721851%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

language of work or name

0 references

publication date

1 April 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7721851%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7721851%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

270

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7721851%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7721851%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

9301-9306

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7721851%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Crystal structure of ovalbumin as a model for the reactive centre of serpins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Structural basis of latency in plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Synthesis of pppGpN typs dinucleotide derivatives: the 5′ end sequence of some RNAs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Characterization of recombinant human alpha 2-antiplasmin and of mutants obtained by site-directed mutagenesis of the reactive site.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Dysfunctional C1-inhibitor(At), isolated from a type II hereditary-angio-oedema plasma, contains a P1 'reactive centre' (Arg444----His) mutation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

On the size of the active site in proteases. I. Papain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Engineering plasminogen activator inhibitor 1 mutants with increased functional stability.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

DNA sequencing with chain-terminating inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Use of T7 RNA polymerase to direct expression of cloned genes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Serine Proteases: Structure and Mechanism of Catalysis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Protein inhibitors of proteinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

On the Kinetics of the Reaction between Human Antiplasmin and Plasmin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Serpin-resistant mutants of human tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Antithrombin III: structural and functional aspects

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Regulation of thrombin activity by antithrombin and heparin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Altered specificities of genetically engineered alpha 1 antitrypsin variants

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Specific glycosaminoglycans support the inhibition of thrombin by plasminogen activator inhibitor 1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

The reaction of thrombin with platelet-derived nexin requires a secondary recognition site in addition to the catalytic site

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.16.9301

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36700767&oldid=1517926274"